Aspen Aerogels Stock Discussion

#ASPN  up over $16.50 a share, trying to decide if to pull the trigger and sell or hold for a little longer.

Aspen Aerogels' high P/S ratio is backed by strong revenue growth, outpacing the Chemicals industry. Investors' confidence in future revenues supports the high P/S ratio and share price. Yet, the company's prospects shouldn't be judged solely on the P/S ratio.

Aspen Aerogel's high P/S ratio is echoed by strong revenue growth, surpassing industry standard. With impressive growth forecasts exceeding industry estimates, the high P/S ratio is justifiable. The stock's rising trend indicates shareholders foresee continued outperformance, with no sharp drop in share price anticipated soon.

Aspen Aerogels has drawn concerns due to its liabilities and absence of EBIT level profitability despite observing 41% revenue growth. Given the debt usage, its current state appears risky, necessitating close monitoring of balance sheet and understanding the high risks tied to the stock.